Irish Health Repository >
Hospital Research >
St. Luke's Hospital >
Browsing "St. Luke's Hospital" by Title
Showing results 1 to 20 of 37
|Issue Date||Title||Author(s)||2008 ||Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma.||Aherne, Noel J; Small, Cormac A; McVey, Gerard P; Fitzpatrick, David G; Armstrong, John G; Department of Radiation Oncology, St, Luke's Hospital, Dublin, Ireland. firstname.lastname@example.org
||Mar-2010 ||Addressing the practicalities of PET-CT fusion in a remote PET centre for the purpose of a PET-CT lung radiotherapy clinical trial. [ICORG 06-35]||Keaveney, M.; McCloy, R.; O'Shea, E.; O'Neill, L.; Lucey, J.; Rangaswamy, G.; Thirion, P.; St Luke's Radiation Oncology Network
||25-May-2012 ||Challenges in the Management of Pediatric Central Venous Access Devices in the Community.||Wallace, Elaine; Twomey, Marie; O'Reilly, Maeve; Department of Palliative Medicine, Our Lady's Hospital for Sick Children , Crumlin, Dublin , Ireland.
||3-Jan-2012 ||A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?||Rock, K; McArdle, O; Forde, P; Dunne, M; Fitzpatrick, D; O'Neill, B; Faul, C; St. Luke's Radiation Oncology Network, Dublin, Ireland, and Beaumont Hospital, Dublin, Ireland.
||10-Dec-2011 ||Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.||D'Amico, Anthony V; Chen, Ming-Hui; Crook, Juanita; Armstrong, John G; Malone, Shawn; Steigler, Allison; Dunne, Mary; Kantoff, Philip W; Denham, James W; Brigham and Women's Hospital, Boston, MA 02115, USA. email@example.com
||Jul-2012 ||The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: an analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01).||Daly, Patricia E; Dunne, Mary T; O'Shea, Carmel M; Finn, Marie A; Armstrong, John G; Department of Radiation Oncology, St. Luke's Hospital, Dublin, Ireland. firstname.lastname@example.org
||Sep-2009 ||Escalated dose for non-small cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. [ICORG 99-09]||Thirion, P.; Brennan, S.; Fitzpatrick, D.; Armstrong, J.; Dunne, M.; O'Shea, C.; McElroy, A.; St. Luke's Radiation Oncology Network
||25-Sep-2011 ||A European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints.||Leonard, Kay; Saint Luke's Radiation Oncology Centre, St James's Hospital, St James's Street, Dublin 8, Ireland.
||May-2012 ||Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.||Reynolds, John V; Donohoe, Claire L; McGillycuddy, Erin; Ravi, Naraymasamy; O'Toole, Dermot; O'Byrne, Ken; Hollywood, Donal; Department of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. email@example.com
||2010 ||Factors influencing conformity index in radiotherapy for non-small cell lung cancer.||Brennan, Sinead M; Thirion, Pierre; Buckney, Steve; Shea, Carmel O; Armstrong, John; Department of Radiation Oncology, St. Lukes Hospital, Dublin, Ireland. firstname.lastname@example.org
||Mar-2011 ||Functional outcomes of patients impending cord compression treated by palliative RT alone [ICORG 05-03]||O'Sullivan, L.; Clayton-Lea, A.; McArdle, O.; McGarry, M.; Kenny, J.; Dunne, M.; O'Shea, E.; St. Luke's Radiation Oncology Network
||Nov-2010 ||How realistic are published dose-response models? [ICORG 99-09]||Walsh, L.; Williams, I.; O'Shea, C.; Armstrong, J.; Thirion, P.; St. Luke's Radiation Oncology Network
||May-2011 ||The impact of rectal and bladder preparation in prostate radiotherapy [ICORG 05-04]||Mullaney, L.; Thirion, P.; Coffey, M.; St Lukes Radiation Oncology Network
||1-Jan-2011 ||In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer.||Murphy, Therese M; Sullivan, Linda; Lane, Caroline; O'Connor, Lisa; Barrett, Ciara; Hollywood, Donal; Lynch, Thomas; Lawler, Mark; Perry, Antoinette S; Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College, Dublin, Ireland. email@example.com
||Nov-2011 ||Management of localised prostatic adenocarcinoma||Rangaswamy, G; Azmi, A.; Ibrahim, N; Thirion, P; Department of Radiation Oncology, St. Luke's Hospital, Dublin, Ireland.
||1-Jun-2011 ||A Method for the Prediction of Late Organ-at-Risk Toxicity After Radiotherapy of the Prostate Using Equivalent Uniform Dose.||Fleming, Cathy; Kelly, Colin; Thirion, Pierre; Fitzpatrick, Kathryn; Armstrong, John; Clinical Trials Unit, St. Luke's Hospital, Rathgar, Dublin Ireland.
||22-May-2012 ||MicroRNAs as putative mediators of treatment response in prostate cancer.||O'Kelly, Fardod; Marignol, Laure; Meunier, Armelle; Lynch, Thomas H; Perry, Antoinette S; Hollywood, Donal; Prostate Molecular Oncology Research Group, Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St James' Hospital & Trinity College, University of Dublin, James's Street, Dublin 8, Ireland.
||Apr-2012 ||mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.||Walsh, S; Flanagan, L; Quinn, C; Evoy, D; McDermott, E W; Pierce, A; Duffy, M J; UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland.
||3-May-2012 ||Multimodal management of retroperitoneal sarcoma||Rangaswamy, Guhan; Gillham, Charles; St. Luke's Hospital, Rathgar, Dublin 6
||2011 ||New targeted therapies for NSCLC.||Carney, D
Showing results 1 to 20 of 37